2022 - Research.com Best Scientist Award
2022 - Research.com Neuroscience in United Kingdom Leader Award
Fellow of The Academy of Medical Sciences, United Kingdom
His primary areas of study are Neuroscience, Parkinson's disease, Internal medicine, Pathology and Putamen. His Prefrontal cortex, Basal ganglia, Supplementary motor area and Dopamine receptor D2 study, which is part of a larger body of work in Neuroscience, is frequently linked to Premotor cortex, bridging the gap between disciplines. His biological study spans a wide range of topics, including Central nervous system disease, Surgery, Transplantation and Dopaminergic.
His work carried out in the field of Internal medicine brings together such families of science as Endocrinology and Cardiology. As part of the same scientific family, David J. Brooks usually focuses on Pathology, concentrating on Microglia and intersecting with Neuroinflammation, In vivo, Pons and Pathogenesis. As a member of one scientific family, David J. Brooks mostly works in the field of Putamen, focusing on Dopamine and, on occasion, Neurotransmitter.
His main research concerns Neuroscience, Parkinson's disease, Internal medicine, Astrophysics and Pathology. David J. Brooks works mostly in the field of Neuroscience, limiting it down to concerns involving Neuroinflammation and, occasionally, Microglia. His Parkinson's disease research includes themes of Dopaminergic, Dopamine, Central nervous system disease and Putamen.
His research in Internal medicine intersects with topics in Endocrinology, Oncology and Cardiology. His research integrates issues of Positron emission tomography and Magnetic resonance imaging in his study of Pathology. David J. Brooks has included themes like Weak gravitational lensing, Telescope and Dark matter in his Dark energy study.
His primary areas of investigation include Astrophysics, Dark energy, Galaxy, Redshift and Internal medicine. He combines subjects such as Weak gravitational lensing, Quasar, Baryon and Planck with his study of Dark energy. His Galaxy research incorporates themes from Photometry and Cluster analysis.
His Internal medicine research is multidisciplinary, relying on both Endocrinology and Cardiology. While the research belongs to areas of Cardiology, David J. Brooks spends his time largely on the problem of Amyloid, intersecting his research to questions surrounding Positron emission tomography. His research on Parkinson's disease concerns the broader Pathology.
David J. Brooks spends much of his time researching Astrophysics, Dark energy, Galaxy, Redshift and Cosmology. Galaxy cluster, Dark matter, Quasar, Galactic halo and Hubble's law are the core of his Astrophysics study. His Dark energy research integrates issues from Weak gravitational lensing, Supernova, Sky and Universe.
David J. Brooks interconnects Photometry, Cluster analysis and Markov chain Monte Carlo in the investigation of issues within Galaxy. His studies deal with areas such as Lens, Methods statistical, Active galactic nucleus and Black hole as well as Redshift. His work focuses on many connections between Cosmology and other disciplines, such as Amplitude, that overlap with his field of interest in COSMIC cancer database.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Neuroinflammation in Alzheimer's disease
Michael T Heneka;Monica J Carson;Joseph El Khoury;Gary E Landreth.
Lancet Neurology (2015)
Second consensus statement on the diagnosis of multiple system atrophy
S. Gilman;G. K. Wenning;P. A. Low;D. J. Brooks.
Neurology (2008)
A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa
Rascol O;Brooks Dj;Korczyn Ad;De Deyn Pp.
The New England Journal of Medicine (2000)
Evidence for striatal dopamine release during a video game
M. J. Koepp;R. N. Gunn;R. N. Gunn;Andrew David Lawrence;Andrew David Lawrence;V. J. Cunningham;V. J. Cunningham.
Nature (1998)
Direct brain infusion of glial cell line–derived neurotrophic factor in Parkinson disease
Steven S Gill;Nikunj K Patel;Gary R Hotton;Karen O'Sullivan.
Nature Medicine (2003)
Motor sequence learning: a study with positron emission tomography
I. H. Jenkins;D. J. Brooks;P. D. Nixon;R. S. J. Frackowiak.
The Journal of Neuroscience (1994)
The functional anatomy of motor recovery after stroke in humans: a study with positron emission tomography.
F. Chollet;V. DiPiero;V. DiPiero;R. J. Wise;D. J. Brooks.
Annals of Neurology (1991)
Self-initiated versus externally triggered movements. I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson's disease subjects
Marjan Jahanshahi;I. H. Jenkins;R. G. Brown;C. D. Marsden.
Brain (1995)
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
Alexander Gerhard;Nicola Pavese;Gary Hotton;Federico Turkheimer.
Neurobiology of Disease (2006)
Core assessment program for intracerebral transplantations (CAPIT).
J. William Langston;Hakan Widner;Christopher G. Goetz;David Brooks.
Movement Disorders (1992)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Aarhus University Hospital
Imperial College London
King's College London
Simon Fraser University
University of Bremen
University of Southern California
National Taiwan University
Stanford University
Central Drug Research Institute
Georgia Institute of Technology
University of California, Davis
Michigan State University
Case Western Reserve University
University of Illinois at Urbana-Champaign
Aristotle University of Thessaloniki
Johns Hopkins University School of Medicine
Mayo Clinic
University of Manchester
University of North Carolina at Chapel Hill